A co-founder and member of the scientific advisory board of the Avicena Group, Dr. M. Flint Beal is an internationally recognized authority on neurodegenerative disorders whose research has focused on the mechanism of neuronal degeneration in Alzheimer's disease, Huntington's disease, Parkinson's disease and amyotrophic lateral sclerosis (ALS). He presently serves as the Anne Parrish Titzell professor and chairman of the department of neurology and neuroscience at the Weill Medical College at Cornell University, and director of neurology at New York Presbyterian Hospital (Cornell campus).
Dr. Beal is also a member of the Alpha Omega Alpha Medical Honorary Society and received the Derek Denny-Brown Neurological Scholar Award of the American Neurologic Association. Recognized for his expertise, Dr. Beal was elected to membership in the Institute of Medicine of the National Academy of Science in 2003. In addition to these prestigious associations, Dr. Beal has also served on the Council of the American Neurologic Association and on the science advisory committees of the Hereditary Disease Foundation, Huntington's Disease Society of America, Parkinson's Disease Study Group, Parkinson' Disease Foundation, Bachman-Strauss Foundation, The ALS Association, and the American Health Assistance Foundation. Dr. Beal is also a member of the Institute of Medicine of the National Academy of Sciences.
Author or co-author of more than 300 scientific articles and more than 125 books, book chapters and reviews, Dr. Beal also serves on the editorial boards of a number of journals including the Journal of Neurochemistry, the Annals of Neurology, Journal of Molecular Neuroscience, Experimental Neurology and Neurobiology of Disease.
Dr. Beal received an M.D. from the University of Virginia Medical School and subsequently conducted residencies in internal medicine at the New York Hospital-Cornell Medical Center and neurology at The Massachusetts General Hospital, respectively. He joined the neurology faculty at Harvard in 1983. Dr. Beal was professor of neurology at the Harvard Medical School and chief of the neurochemistry laboratory at Massachusetts General Hospital before moving to Cornell. |